Third Avenue Management LLC Has $31.87 Million Holdings in LivaNova PLC (LIVN)
Third Avenue Management LLC lowered its stake in shares of LivaNova PLC (NASDAQ:LIVN) by 0.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 520,671 shares of the company’s stock after selling 1,239 shares during the period. LivaNova PLC accounts for about 1.4% of Third Avenue Management LLC’s investment portfolio, making the stock its 19th biggest holding. Third Avenue Management LLC owned approximately 1.08% of LivaNova PLC worth $31,871,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the business. PNC Financial Services Group Inc. lifted its holdings in shares of LivaNova PLC by 9.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after purchasing an additional 153 shares during the last quarter. Riverhead Capital Management LLC lifted its holdings in shares of LivaNova PLC by 76.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock valued at $108,000 after purchasing an additional 763 shares during the last quarter. Meadow Creek Investment Management LLC lifted its holdings in shares of LivaNova PLC by 11.4% during the 1st quarter. Meadow Creek Investment Management LLC now owns 2,464 shares of the company’s stock valued at $121,000 after purchasing an additional 252 shares during the last quarter. Exane Derivatives lifted its holdings in shares of LivaNova PLC by 814.8% during the 2nd quarter. Exane Derivatives now owns 3,156 shares of the company’s stock valued at $158,000 after purchasing an additional 2,811 shares during the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in shares of LivaNova PLC during the 2nd quarter valued at $204,000. Institutional investors own 82.26% of the company’s stock.
Several analysts have recently commented on the company. Berenberg Bank reiterated a “buy” rating and set a $70.00 price objective on shares of LivaNova PLC in a report on Friday, August 11th. Canaccord Genuity reiterated a “hold” rating and set a $71.00 price objective on shares of LivaNova PLC in a report on Wednesday, September 20th. Jefferies Group LLC increased their price objective on LivaNova PLC from $76.00 to $80.00 and gave the company a “buy” rating in a report on Friday, September 15th. BidaskClub lowered LivaNova PLC from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. Finally, WBB Securities lowered LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price objective for the company. in a report on Tuesday, August 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. LivaNova PLC presently has a consensus rating of “Hold” and an average price target of $71.50.
In related news, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $60.76, for a total value of $60,760.00. Following the completion of the sale, the director now directly owns 58,296 shares of the company’s stock, valued at $3,542,064.96. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Over the last three months, insiders sold 3,000 shares of company stock valued at $190,860. 0.28% of the stock is owned by corporate insiders.
LivaNova PLC (NASDAQ:LIVN) traded up 0.89% during trading on Friday, hitting $70.06. The company had a trading volume of 236,921 shares. LivaNova PLC has a 52-week low of $40.83 and a 52-week high of $70.50. The stock has a market capitalization of $3.42 billion, a price-to-earnings ratio of 125.11 and a beta of 0.58. The firm’s 50 day moving average is $62.98 and its 200-day moving average is $57.94.
LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.19. LivaNova PLC had a net margin of 2.26% and a return on equity of 9.08%. The firm had revenue of $321.40 million during the quarter, compared to analysts’ expectations of $315.75 million. The firm’s revenue for the quarter was up .1% on a year-over-year basis. On average, equities analysts forecast that LivaNova PLC will post $3.25 earnings per share for the current year.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Stock Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related stocks with our FREE daily email newsletter.